Tobón GJ - Search Results

1

The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome.

Tobón GJ, Renaudineau Y, Hillion S, Cornec D, Devauchelle-Pensec V, Youinou P, Pers JO. Tobón GJ, et al. Arthritis Rheum. 2010 Nov;62(11):3447-56. doi: 10.1002/art.27611. Arthritis Rheum. 2010. PMID: 20556820 Free article.

2

B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.

Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers JO, Jousse-Joulin S, Saraux A. Cornec D, et al. Among authors: tobon gj. J Autoimmun. 2012 Sep;39(3):161-7. doi: 10.1016/j.jaut.2012.05.014. Epub 2012 Jun 30. J Autoimmun. 2012. PMID: 22749831 Review.

3

Pathophysiological cytokine network in primary Sjögren's syndrome.

Pers JO, Lahiri A, Tobón GJ, Youinou P. Pers JO, et al. Among authors: tobon gj. Presse Med. 2012 Sep;41(9 Pt 2):e467-74. doi: 10.1016/j.lpm.2012.04.029. Epub 2012 Jul 24. Presse Med. 2012. PMID: 22836197 Review.

4

Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.

Tobón GJ, Saraux A, Gottenberg JE, Quartuccio L, Fabris M, Seror R, Devauchelle-Pensec V, Morel J, Rist S, Mariette X, De Vita S, Youinou P, Pers JO. Tobón GJ, et al. Arthritis Rheum. 2013 Dec;65(12):3218-27. doi: 10.1002/art.38129. Arthritis Rheum. 2013. PMID: 23982978 Free article.

5

Emerging biotherapies for Sjögren's syndrome.

Tobón GJ, Saraux A, Pers JO, Youinou P. Tobón GJ, et al. Expert Opin Emerg Drugs. 2010 Jun;15(2):269-82. doi: 10.1517/14728211003702392. Expert Opin Emerg Drugs. 2010. PMID: 20384543 Review.

6

Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren's syndrome.

Roguedas AM, Pers JO, Lemasson G, Devauchelle V, Tobón GJ, Saraux A, Misery L, Youinou P. Roguedas AM, et al. Among authors: tobon gj. J Autoimmun. 2010 Nov;35(3):241-7. doi: 10.1016/j.jaut.2010.06.014. Epub 2010 Jul 22. J Autoimmun. 2010. PMID: 20655174

7

Neurological Disorders in Primary Sjögren's Syndrome.

Tobón GJ, Pers JO, Devauchelle-Pensec V, Youinou P. Tobón GJ, et al. Autoimmune Dis. 2012;2012:645967. doi: 10.1155/2012/645967. Epub 2012 Mar 5. Autoimmune Dis. 2012. PMID: 22474573 Free PMC article.

8

B cell-targeted therapies in Sjögren's syndrome.

Tobón GJ, Pers JO, Youinou P, Saraux A. Tobón GJ, et al. Autoimmun Rev. 2010 Feb;9(4):224-8. doi: 10.1016/j.autrev.2009.08.001. Epub 2009 Aug 9. Autoimmun Rev. 2010. PMID: 19671451 Review.

9

Membrane microdomain sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells.

Hammadi M, Youinou P, Tempescul A, Tobón G, Berthou C, Bordron A, Pers JO. Hammadi M, et al. Haematologica. 2012 Feb;97(2):288-96. doi: 10.3324/haematol.2011.051938. Epub 2011 Nov 4. Haematologica. 2012. PMID: 22058197 Free PMC article.

10

First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort.

Tobón G, Saraux A, Lukas C, Gandjbakhch F, Gottenberg JE, Mariette X, Combe B, Devauchelle-Pensec V. Tobón G, et al. Arthritis Care Res (Hoboken). 2013 Dec;65(12):1907-15. doi: 10.1002/acr.22078. Arthritis Care Res (Hoboken). 2013. PMID: 23861163 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters